Elevated levels of cortisol, the end hormone produced by the activation of the hypothalamic–pituitary–adrenal (HPA) axis, and of inflammatory markers, such interleukin (IL)-6, have been consistently shown in first-episode, drug-naive schizophrenia patients [19–21]. Here, IL6 is linked to schizophrenia.